Mkts

Astrana Health Inc.

NASDAQ: ASTH
$36.53-0.09 (-0.25%)
As of Oct 30, 4:00 PM ET

Key statistics

Day range
35.8436.76
52-week range
18.0851.60
Today
Open36.62
Previous close36.53
Volume336.6K
Valuation
Market cap1.79B
P/E ratio44.08×
EPS (TTM)0.82
Income & risk
Dividend / yield—
Beta1.24
Avg volume494.6K
Discussion

ASTH News

Stories mentioning ASTH from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue965,100950,523956,048654,808620,390665,209478,710486,265
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)28,52818,39219,21020,34020,583720.0028,42530,066
Interest Income3,8163,9873,5222,3362,3123,2213,7783,513
Interest Expense8,587
Other Expense662.00703.00445.001,136(5,072)353.002,6736,126
Pretax Income19,7097,5065,67116,8259,604(1,895)26,81231,897
Tax Provision6,578944.004,5946,6093,3835,8827,83110,031
Net Income (Loss)14,4365,999373.009,4236,692(6,951)16,09419,171
Earnings Per Share (Basic)0.300.120.010.190.14(0.15)0.340.40
Earnings Per Share (Diluted)0.290.120.010.190.14(0.14)0.330.40
Weighted Average Shares Outstanding (Basic)48,85449,07649,21749,18848,47147,59747,68747,615
Weighted Average Shares Outstanding (Diluted)49,05449,37049,47349,47148,85147,97448,22447,978

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ASTH

Astrana Health Inc. (NASDAQ: ASTH) is a stock listed on the Nasdaq Stock Market under the ticker symbol ASTH. It last traded at $36.53 (Oct 30, 2026, 4:00 PM ET), down 0.3% on the day. That gives Astrana Health a market capitalisation of $1.8B and a price-to-earnings ratio of 44.1.

Over the past 52 weeks ASTH has traded between $18.08 and $51.60.

Revenue for the quarter ended Mar 31, 2026 was $965.1M; net income $14.4M. Revenue was up 55.6% from $620.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$965.1M$14.4M1.5%
Dec 31, 2025$950.5M$6.0M0.6%
Sep 30, 2025$956.0M$373.0K0.0%
Jun 30, 2025$654.8M$9.4M1.4%

From Astrana Health’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…